Potential for personalised application of inhaled nitric oxide in Covid-19 pneumonia
B. Garfield (London, United Kingdom), C. Mcfadyen (London, United Kingdom), C. Briar (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Ledot (London, United Kingdom), M. Baldwin (London, United Kingdom), K. Vlachou (London, United Kingdom), S. Price (London, United Kingdom), S. Wort (London, United Kingdom), B. Patel (London, United Kingdom), L. Price (London, United Kingdom)
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Session: Respiratory failure in COVID19 and beyond
Session type: E-poster
Number: 3325
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Garfield (London, United Kingdom), C. Mcfadyen (London, United Kingdom), C. Briar (London, United Kingdom), C. Mccabe (London, United Kingdom), S. Ledot (London, United Kingdom), M. Baldwin (London, United Kingdom), K. Vlachou (London, United Kingdom), S. Price (London, United Kingdom), S. Wort (London, United Kingdom), B. Patel (London, United Kingdom), L. Price (London, United Kingdom). Potential for personalised application of inhaled nitric oxide in Covid-19 pneumonia. 3325
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Predicting response to corticosteroid in COPD using exhaled nitric oxide Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Feasibility of home treatment with inhaled nitric oxide for primary pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020
Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019
The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003
Investigation on the effectiveness of the Mostgraph and fractional exhaled nitric oxide measurement in chronic cough Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012
Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020
The role of exhaled nitric oxide in the evaluation of chronic cough Source: Eur Respir J 2006; 28: Suppl. 50, 794s Year: 2006
Experiences of exhaled nitric oxide measurements in diagnostics of occupational asthma Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001
Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002
Acinar effect of inhaled steroids therapy evidenced by exhaled nitric oxide Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Exhaled nitric oxide in the assessment of asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 18s Year: 2007
Effect of caffeine on exhaled nitric oxide measurements in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003
Exhaled nitric oxide increases in chronic eosinophilic pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002